Company Quick10K Filing
Israel Chemicals
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 1,305 $7,464
20-F 2019-02-27 Annual: 2018-12-31
20-F 2018-03-07 Annual: 2017-12-31
20-F 2017-03-16 Annual: 2016-12-31
20-F 2016-03-16 Annual: 2015-12-31

Israel Chemicals Financials

ICL Metrics, Comps, Filings

Annual | Quarterly

Business

Our legal name is Israel Chemicals Ltd. and our commercial name is ICL. We are a public company and operate today as a limited liability company under the laws of Israel. Our registered headquarters is located at Millennium Tower, 23 Aranha Street, P.O. Box 20245, Tel Aviv 61202, Israel. The telephone number at our registered office is +972‑3‑684‑4400. Our website address is www.icl‑group.com. The reference to our website is intended to be an inactive textual reference and the information on, or accessible through, our website is not intended to be part of this Annual Report.

ICL was established in Israel in 1968 as a government-owned and -operated company in Israel, and operates today as a limited liability company under the laws of Israel. In 1975, the shares of certain companies (including, among others, ICL Dead Sea, the consolidated companies ICL Rotem, the bromine companies and Tami) were transferred to ICL. In 1992, following a decision of the Israeli government to privatize ICL, the State published its tender prospectus, 20% of the Company's shares were sold to the public and its shares were registered for trading on the Tel‑Aviv Stock Exchange. Prior to our public share issuance, a Special State Share in our Company and our main Israeli subsidiaries was issued to the State of Israel (for additional details regarding the terms of the Special State Share, see "Item 10 - Additional Information- B. Memorandum, Articles of Association and Special State Share"). In 1995, the State of Israel sold its controlling interest in the Company (representing approximately 24.9% of our shares) to Israel Corporation Ltd., a public traded Company on the TASE (ILCO), which was controlled at that time by the Eisenberg family. A majority of the ordinary shares held by the state of Israel were sold during the following years. In 2000, the State of Israel ceased to be a stakeholder in terms of holding any of our ordinary shares, but it retained the Special State Share. In 1999, the Ofer Group acquired the Eisenberg family's shares in Israel Corporation. In September 2014, we listed our shares on the New York Stock Exchange, and they are currently traded in Tel Aviv and in New York.

As of December 31, 2018, Israel Corporation Ltd. holds approximately 45% of our outstanding ordinary shares and approximately 45.87% of the shareholders' voting rights.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CF Industries (CF) 11,150 24% 7.8 5% 12,863 9,797 4,675 1,134 651 1,936 15,042
Mosaic (MOS) 9,315 21% 10.9 1% 20,644 10,171 7,268 1,498 262 1,236 13,439
Fortune Brands (FBHS) 7,822 27% 11.8 6% 6,343 3,999 5,637 1,498 407 782 9,204
Israel Chemicals (ICL) 7,464 0% 8,776 4,861 0 0 0 0 7,464
Albemarle (ALB) 7,392 35% 9.7 7% 8,094 4,294 3,417 1,210 600 914 8,883
Axalta Coating Systems (AXTA) 7,078 25% 13.1 3% 6,693 5,386 4,589 1,166 209 791 10,395
Agnico Eagle Mines (AEM) 6,846 0% 5,256 1,846 0 0 0 0 7,378
Steel Dynamics (STLD) 6,793 18% 4.4 14% 7,858 3,810 11,715 2,062 1,069 1,875 8,314
Scotts Miracle-Gro (SMG) 5,478 32% 11.0 11% 3,467 2,662 3,092 1,004 372 671 7,376
Calyxt (CLXT) 585 91% -16.4 -28% 111 23 0 0 -31 -31 499
CVR Partners (UAN) 452 20% 13.6 -0% 1,190 699 408 81 -2 75 1,013
American Vanguard (AVD) 424 40% 10.9 3% 666 332 456 182 21 54 582
Marrone (MBII) 182 53% -15.1 -30% 52 43 26 14 -16 -12 184
Evogene (EVGN) 81 0% 59 0 0 0 0 79
Senestech (SNES) 38 34% -3.8 -182% 5 1 0 0 -10 -9 36
China Green Agriculture (CGA) 20 30% -1.6 -2% 482 78 218 65 -11 31 -49
Arcadia Biosciences (RKDA) 2 0% 3.0 -18% 25 17 1 0 -5 -4 -13
Bioceres Crop Solutions (BIOX)
Nutrien (NTR)

Balance Sheet ($MM)2017-12-312018-12-31
Cash
Accounts Receivable
Inventory
PP&E
Assets8,7148,776
Accounts Payable
Long-Term Debt
Liabilities5,7844,861
Stockholders' Equity
Income Statement ($MM)2017-12-312018-12-31
Revenue5,4185,556
Cost of Revenue3,7463,702
Gross Profit1,6721,854
R&D5555
SG&A261257
Tax
Net Income3471,235
Cash Flow ($MM)2017-12-312018-12-31
Cash Operating
Cash Investing
Cash Financing